Ligand-Based 3D-QSAR Studies of Diaryl Acyl-sulfonamide Analogues as Human Umbilical Vein Endothelial Cells Inhibitors Stimulated by VEGF

Chemical Biology and Drug Design

Volumn 77, Issue 4, 2011, Pages 288-294

  Ul Haq, Zaheer ^a   Mahmood, Uzma ^a   Reza, Sualeha ^a   Uddin, Reaz ^a   Aleem, Mehwish ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Comparative molecular field analysis; Human umbilical vein endothelial cells; Three dimensional quantitative structure activity relationship; Vascular endothelial growth factor

Indexed keywords

ACYLSULFONAMIDE; ANTINEOPLASTIC AGENT; SULFONAMIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTICLE; COMPARATIVE MOLECULAR FIELD ANALYSIS; DRUG BINDING; DRUG DESIGN; DRUG INHIBITION; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING; UMBILICAL VEIN ENDOTHELIAL CELL; VALIDATION PROCESS;

ENDOTHELIAL CELLS; HUMANS; LIGANDS; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952614253     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2011.01084.x     Document Type: Article

References (25)

1. Fujisaki K., Mitsuyama K., Toyonaga A., Matsuo K., Tanikawa K. (1998) Circulating vascular endothelial growth factor in patients with colorectal cancer. Am J Gastroenterol;93:249-252.
2. Muller Y.A., Li B., Christinger H.W., Wells J.A., Cunningham B.C., De Vos A.M. (1997) Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proc Nat Acad Sci;94:7192-7197.
3. Muller Y.A., Christinger H.W., Keyt B.A., de Vos A.M. (1997) The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding. Structure;5:1325-1338.
4. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., Ferrara N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature;362:841-844.
5. De Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science;255:989-991.
6. Terman B.I., Dougher-Vermazen M., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D. (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun;187:1579-1586.
7. Wiesmann C., Fuh G., Christinger H.W., Eigenbrot C., Wells J.A., De Vos A.M. (1997) Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell;91:695-704.
8. Lobb K.L., Hipskind P.A., Aikins J.A., Alvarez E., Cheung Y.Y., Considine E.L., De Dios A., Durst G.L., Ferritto R., Grossman C.S. (2004) Acyl sulfonamide anti-proliferatives: benzene substituent structure- activity relationships for a novel class of antitumor agents. J Med Chem;47:5367-5380.
9. Ul-Haq Z., Mahmood U., Jehangir B. (2009) Ligand-based 3D-QSAR Studies of Physostigmine Analogues as Acetylcholinesterase Inhibitors. Chem Biol Drug Des;74:571-581.
10. Ul-Haq Z., Uddin R., Yuan H., Petukhov P.A., Choudhary M.I., Madura J.D. (2008) Receptor-based modeling and 3D-QSAR for a quantitative production of the butyrylcholinesterase inhibitors based on genetic algorithm. J Chem Inf Model;48:1092-1103.
11. Zeng H., Cao R., Zhang H. (2009) Combined 3D-QSAR Modeling and Molecular Docking Study on Quinoline Derivatives as Inhibitors of P-selectin. Chem Biol Drug Des;74:596-610.
12. Bohacek R.S., McMartin C. (1992) Definition and display of steric, hydrophobic, and hydrogen bonding properties of ligand binding sites in proteins using Lee and Richards accessible surface: validation of a high-resolution graphical tool for drug design. J Med Chem;35:1671-1684.
13. Ul-Haq Z., Wadood A., Uddin R. (2009) CoMFA and CoMSIA 3D-QSAR analysis on hydroxamic acid derivatives as urease inhibitors. J Enzyme Inhib Med Chem;24:272-278.
14. McFarland J.W. (1992) Comparative molecular field analysis of anticoccidial triazines. J Am Chem Soc;35:2543-2550.
15. Bohm M., Sturzebecher J., Klebe G. (1999) Three-Dimensional Quantitative Structure- Activity Relationship Analyses Using Comparative Molecular Field Analysis and Comparative Molecular Similarity Indices Analysis To Elucidate Selectivity Differences of Inhibitors Binding to Trypsin, Thrombin, and Factor Xa. J Med Chem;42:458-477.
16. Ravichandran V., Agrawal R.K. (2007) Predicting anti-HIV activity of PETT derivatives: CoMFA approach. Bioorg Med Chem Lett;17:2197-2202.
17. Zambre V.P., Murumkar P.R., Giridhar R., Yadav M.R. (2009) Structural Investigations of Acridine Derivatives by CoMFA and CoMSIA Reveal Novel Insight into Their Structures toward DNA G-Quadruplex Mediated Telomerase Inhibition and Offer a Highly Predictive 3D-Model for Substituted Acridines. J Chem Inf Model;49:1298-1311.
18. Verli H., Albuquerque M.G., de Alencastro R.B., Barreiro E.J. (2002) Local intersection volume: a new 3D descriptor applied to develop a 3D-QSAR pharmacophore model for benzodiazepine receptor ligands. J Med Chem;37:219-229.
19. Amin E.A., Welsh W.J. (2001) Three-Dimensional Quantitative Structure- Activity Relationship (3D-QSAR) Models for a Novel Class of Piperazine-Based Stromelysin-1 (MMP-3) Inhibitors: Applying a "Divide and Conquer" Strategy. J Med Chem;44:3849-3855.
20. Gasteiger J., Marsili M. (1980) Iterative partial equalization of orbital electronegativity-A rapid access to atomic charges. Tetrahedron;36:3219-3228.
21. Cheng A., Best S.A., Merz K.M., Reynolds C.H. (2000) GB/SA water model for the Merck molecular force field (MMFF). J Mol Graphics & Modell;18:273-282.
22. Cramer R.D., Patterson D., Bunce J. (1988) Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J Am Chem Soc;110:5959-5967.
23. Kroemer R.T., Hecht P. (1995) Replacement of steric 6-12 potential-derived interaction energies by atom-based indicator variables in CoMFA leads to models of higher consistency. J Comput Aided Mol Des;9:205-212.
24. Clark M., Cramer R.D., Van Opdenbosch N. (1989) Validation of the general purpose tripos 5. 2 force field. J Comput Chem;10:982-1012.
25. Bush B.L., Nachbar R.B. (1993) Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J Comput Aided Mol Des;7:587-619.